V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330003459 | 330001780 | 1.54 | 107 | Curative (C) | 2017-09-28 | 2017-10-01 | CETUXIMAB | N | N | 330012906 | CETUXIMAB |
| 330003460 | 330001780 | null | 82 | Palliative (P) | 2015-03-12 | 2015-03-14 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 330012906 | CISPLATIN + GEMCITABINE |
| 330003461 | 330001781 | 1.75 | 63.15 | Palliative (P) | 2016-02-01 | 2016-02-10 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | Y | 330012909 | CISPLATIN + GEMCITABINE |
| 330003462 | 330001782 | 1.63 | 49 | Palliative (P) | 2013-09-14 | 2013-09-19 | CVP R | N | N | 330012913 | CVP R |
| 330003463 | 330001782 | 1.7 | 38.5 | Curative (C) | 2016-11-27 | 2016-11-27 | CVP R | N | N | 330012913 | CVP R |
| 330003464 | 330009758 | null | null | Curative (C) | 2018-07-07 | 2018-07-07 | Cetuximab 7 day (Cycle 1) | N | N | 330012917 | CETUXIMAB |
| 330003465 | 330001783 | 1.74 | 30 | Palliative (P) | 2013-05-15 | 2013-05-27 | CAP | N | N | 330012920 | CAP |
| 330003466 | 330001784 | 1.77 | 98.5 | Palliative (P) | 2015-03-10 | 2015-03-18 | Cisplatin + Gemcitabine (D 1 & 8) | 2 | N | 330012921 | CISPLATIN + GEMCITABINE |
| 330003467 | 330006957 | 1.83 | 72.4 | Neo-adjuvant (N) | 2016-04-11 | 2016-04-17 | Dox + HD Mtx (post PAM) | N | N | 330012923 | DOXORUBICIN + HD MTX |
| 330003468 | 330001785 | 1.66 | 72.5 | Curative (C) | 2016-12-12 | 2017-01-01 | Cetuximab 7 day (Cycle 1) | N | Y | 330012924 | CETUXIMAB |
| 330003469 | 330001785 | null | null | Palliative (P) | 2017-07-08 | 2017-07-16 | Cisplatin + Gemcitabine (D 1 & 8) | null | N | 330012924 | CISPLATIN + GEMCITABINE |
| 330003470 | 330001786 | 1.67 | 51 | Neo-adjuvant (N) | 2017-01-20 | 2017-01-22 | CAP | 2 | null | 330012926 | CAP |
| 330003471 | 330001786 | 1.65 | 109.8 | Curative (C) | 2015-12-06 | 2015-12-12 | EURO-EWING | 02 | N | 330012926 | EURO-EWING |
| 330003472 | 330001787 | 1.6 | 75 | Neo-adjuvant (N) | 2017-01-22 | 2017-01-29 | OST Euramos 1 Closed Trial - AP | N | N | 330012931 | MAP |
| 330003473 | 330001787 | 1.67 | 89.999 | Adjuvant (A) | 2013-03-07 | 2013-03-14 | Carbo F | N | N | 330012931 | CARBO + FLUOROURACIL |
| 330003474 | 330001788 | 1.79 | 60 | null | 2014-07-05 | 2014-07-05 | EURAMOS TRIAL | 02 | N | 330012935 | EURAMOS TRIAL |
| 330003475 | 330001789 | 1.68 | 84.8 | Curative (C) | 2017-03-18 | 2017-03-20 | EW EuroEwing 99 : VIDE | 02 | N | 330012936 | EURO-EWING |
| 330003476 | 330001789 | null | 151.7 | null | 2014-12-28 | 2014-12-28 | Cetuximab + Radiotherapy Load | 2 | Y | 330012936 | CETUXIMAB + RT |
| 330003477 | 330001790 | 1.64 | 49.2 | Curative (C) | 2013-08-30 | 2013-10-06 | CETUXIMAB | 02 | N | 330012948 | CETUXIMAB |
| 330003478 | 330001790 | 1.82 | 60.9 | Neo-adjuvant (N) | 2014-07-22 | 2014-07-22 | Cisplatin + Etoposide (5 day) | 02 | null | 330012948 | CISPLATIN + ETOPOSIDE |
| 330003479 | 330001791 | 1.71 | 84 | Neo-adjuvant (N) | 2014-07-22 | 2014-07-22 | MAP | N | N | 330012955 | MAP |
| 330003482 | 330001793 | null | 85 | Neo-adjuvant (N) | 2014-12-24 | 2015-01-13 | OST Euramos 1 Closed Trial - AP | N | N | 330012962 | MAP |
| 330003483 | 330001793 | 1.57 | 57.2 | Palliative (P) | 2017-06-08 | 2017-06-08 | GemCarbo Days 1+8 | N | N | 330012962 | GEMCARBO |
| 330003484 | 330001793 | 1.46 | 53.1 | Curative (C) | 2013-09-27 | 2013-09-27 | OST Euramos 1 Closed Trial - AP | 02 | N | 330012962 | MAP |
| 330003485 | 330001793 | 1.7 | 86.9 | null | 2017-09-12 | 2017-09-18 | CVP R | N | N | 330012962 | CVP R |
| 330003486 | 330001793 | 1.77 | 74.1 | Curative (C) | 2013-07-13 | 2013-07-27 | CYTARABINE + DAUNORUBICIN | 02 | N | 330012962 | DA |
| 330003487 | 330001793 | 0 | 52.8 | Disease modification (D) | 2016-09-20 | 2016-09-23 | Cyclophosphamide + Dex + Rituximab | N | N | 330012962 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 330003488 | 330001793 | 1.63 | null | Palliative (P) | 2015-03-21 | 2015-03-22 | GemCarbo Days 1+8 | null | N | 330012962 | GEMCARBO |
| 330003489 | 330001793 | 1.85 | 70 | Curative (C) | 2017-02-22 | 2017-03-13 | Cetuximab 7 day (Cycle 1) | N | Y | 330012962 | CETUXIMAB |
| 330003490 | 330013216 | 1.64 | 56.4 | Palliative (P) | null | 2017-12-29 | CISPLATIN + ETOPOSIDE | N | N | 330012978 | CISPLATIN + ETOPOSIDE |
| 330003491 | 330001794 | 1.57 | 51.3 | Curative (C) | 2017-04-07 | 2017-04-25 | EW EuroEwing 99 : VIDE | 02 | N | 330012982 | EURO-EWING |
| 330003492 | 330006965 | 1.75 | 77 | Neo-adjuvant (N) | 2013-03-18 | 2013-04-01 | CISPLATIN + GEMCITABINE | 2 | null | 330012985 | CISPLATIN + GEMCITABINE |
| 330003493 | 330001795 | 1.71 | 39 | null | 2016-09-07 | 2016-09-25 | Carbo F | 02 | N | 330012987 | CARBO + FLUOROURACIL |
| 330003494 | 330001796 | 0 | 58.7 | Neo-adjuvant (N) | 2013-05-11 | 2013-05-24 | EW EuroEwing 99 : VIDE | 02 | null | 330012992 | EURO-EWING |
| 330003495 | 330006966 | 1.62 | 91.3 | Neo-adjuvant (N) | 2016-04-01 | 2016-04-01 | OST Euramos 1 Closed Trial - AP | 2 | N | 330012994 | MAP |
| 330003496 | 330001797 | 1.59 | 59 | Curative (C) | null | 2015-12-22 | CETUXIMAB | N | Y | 330012995 | CETUXIMAB |
| 330003497 | 330001797 | 1.68 | 41.2 | Disease modification (D) | 2015-02-11 | 2015-02-18 | CVP R | 02 | N | 330012995 | CVP R |
| 330003498 | 330001797 | 1.6 | 39.5 | Neo-adjuvant (N) | 2013-12-22 | 2013-12-28 | OST Euramos 1 Closed Trial - AP | N | N | 330012995 | MAP |
| 330003499 | 330001798 | 1.65 | 50 | Palliative (P) | 2015-07-17 | 2015-07-18 | Cisplatin + Etoposide po&iv 3 day | Y | N | 330012999 | CISPLATIN + ETOPOSIDE |
| 330003500 | 330006968 | null | null | Neo-adjuvant (N) | 2016-11-13 | 2016-11-14 | Cisplatin + Gemcitabine (D 1 & 8) | null | N | 330013003 | CISPLATIN + GEMCITABINE |
| 330003501 | 330001799 | 1.58 | 51 | Palliative (P) | 2013-11-12 | 2013-11-13 | CISPLATIN + ETOPOSIDE | 02 | null | 330013004 | CISPLATIN + ETOPOSIDE |
| 330003502 | 330001800 | null | 93.5 | Neo-adjuvant (N) | 2017-03-17 | 2017-03-29 | EW EuroEwing 2012 Arm A VIDE | null | N | 330013005 | EURO-EWING |
| 330003503 | 330001801 | 1.45 | 63.5 | Adjuvant (A) | 2017-01-07 | 2017-01-07 | EURAMOS TRIAL | 02 | N | 330013006 | EURAMOS TRIAL |
| 330003504 | 330006969 | null | 59.1 | Neo-adjuvant (N) | 2018-01-24 | 2018-02-04 | CARBOPLATIN + GEMCITABINE | N | N | 330013010 | GEMCARBO |
| 330003505 | 330006969 | 0 | null | Curative (C) | 2017-08-15 | 2017-08-27 | CETUXIMAB + RT | N | N | 330013010 | CETUXIMAB + RT |
| 330003506 | 330006969 | 1.78 | null | Curative (C) | 2014-06-02 | 2014-06-17 | CISPLATIN + GEMCITABINE | N | N | 330013010 | CISPLATIN + GEMCITABINE |
| 330003507 | 330006969 | 1.85 | 77.2 | Neo-adjuvant (N) | 2017-10-26 | 2017-11-08 | GemCarbo Days 1+8 | N | N | 330013010 | GEMCARBO |
| 330003508 | 330001802 | 0 | 90.7 | Curative (C) | 2013-06-26 | 2013-06-26 | Cetuximab + Radiotherapy Load | 02 | N | 330013024 | CETUXIMAB + RT |
| 330003509 | 330001802 | 0 | null | Neo-adjuvant (N) | 2016-10-08 | 2016-10-08 | EW EuroEwing 2012 Arm A VIDE | 02 | null | 330013024 | EURO-EWING |
| 330003510 | 330001803 | 1.68 | 63.9 | Curative (C) | 2014-05-11 | 2014-05-11 | Carbo F | 02 | N | 330013034 | CARBO + FLUOROURACIL |